These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38834088)

  • 61. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Is there an advantage to neo- or adjuvant chemotherapy in pancreatic cancer?].
    Klapdor R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():135-47. PubMed ID: 1724194
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.
    Boeck S; Heinemann V
    J Clin Oncol; 2008 Mar; 26(7):1178-9; author reply 1179. PubMed ID: 18309957
    [No Abstract]   [Full Text] [Related]  

  • 64. Adenosine in pancreatic cancer: Emerging combination therapies.
    Roth S; Hackert T
    EBioMedicine; 2019 Oct; 48():20-21. PubMed ID: 31590927
    [No Abstract]   [Full Text] [Related]  

  • 65. Metastatic pancreatic adenocarcinoma: current standards, future directions.
    Duffy A; Kummar S
    Am J Ther; 2010; 17(1):79-85. PubMed ID: 19636248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pancreatic ductal adenocarcinoma: metastatic disease.
    Muñoz Martín AJ; Adeva J; Martínez-Galán J; Reina JJ; Hidalgo M
    Clin Transl Oncol; 2017 Dec; 19(12):1423-1429. PubMed ID: 28623515
    [TBL] [Abstract][Full Text] [Related]  

  • 67. FOLFIRINOX: a small step or a great leap forward?
    Ko AH
    J Clin Oncol; 2011 Oct; 29(28):3727-9. PubMed ID: 21900100
    [No Abstract]   [Full Text] [Related]  

  • 68. Cytology of solid and papillary epithelial neoplasms of the pancreas: a case report.
    Stachura J; Popiela T; Pietroń M; Tomaszewska R; Kulig J; Nowak K
    Diagn Cytopathol; 1988; 4(4):339-41. PubMed ID: 3254813
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Two cases of CPT-11 and CDDP chemotherapy for advanced pancreatic cancer].
    Takagi K; Kawamoto K; Itoh T
    Gan To Kagaku Ryoho; 2012 May; 39(5):847-9. PubMed ID: 22584347
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pancreatic cancer: will incremental advances begin to make a difference?
    Holzman DC
    J Natl Cancer Inst; 2010 Dec; 102(24):1821-3. PubMed ID: 21139096
    [No Abstract]   [Full Text] [Related]  

  • 71. Pancreatic cancer: an update.
    Kindler HL
    Curr Oncol Rep; 2007 May; 9(3):170-6. PubMed ID: 17430687
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Has there been progress in the treatment of metastatic pancreatic cancer?].
    Jerusalem G; Bours V; Fillet G
    Rev Med Liege; 2000 Mar; 55(3):146-8. PubMed ID: 10823002
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular Characterization and Treatment of Pancreatic Neuroendocrine Tumors.
    De Jesus-Acosta AMC
    Oncology (Williston Park); 2019 Dec; 33(12):. PubMed ID: 31914198
    [No Abstract]   [Full Text] [Related]  

  • 74. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
    Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
    [No Abstract]   [Full Text] [Related]  

  • 75. [Carcinoma of the pancreas: adjuvant and neoadjuvant treatment].
    Enrici RM; Santoro M
    Suppl Tumori; 2002; 1(3):S18-21. PubMed ID: 12415780
    [No Abstract]   [Full Text] [Related]  

  • 76. Erlotinib in pancreatic cancer patients: do we need more information from the NCIC CTG trial?
    Mandalà M; Moro C; Labianca R; Ferretti G
    J Clin Oncol; 2007 Sep; 25(27):4320-1; author reply 4321-2. PubMed ID: 17878488
    [No Abstract]   [Full Text] [Related]  

  • 77. [Pancreatic Cancer in the Year 2018 - Room for Precision Medicine?].
    Simon O; Beyer G; Mahajan UM; Mayerle J
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1109-1112. PubMed ID: 30060283
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phase 1 trials in pancreatic cancer.
    Yu E; Saif MW; Huber K
    JOP; 2014 Jul; 15(4):326-8. PubMed ID: 25076334
    [TBL] [Abstract][Full Text] [Related]  

  • 79. State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
    Balsano R; Tommasi C; Garajova I
    Anticancer Res; 2019 Jul; 39(7):3405-3412. PubMed ID: 31262862
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metastatic pancreatic cancer: abdominal pain in a 22-year-old woman.
    Roy BT; Roy RB
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26611479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.